U.S. hospitals facing shortage of dye needed for life-saving scans
May 19, 2022
The shortage is expected to last until at least June 30, according to the American Hospital Association.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
BMI tied to pain in patients with hand osteoarthritis
Feb 23, 2022
A higher body mass index was linked to greater severity of pain in the hands, feet and knees/hips.
MRI of hand, foot may predict rheumatoid arthritis in undifferentiated arthritis
Jan 24, 2022
MRI-detected tenosynovitis was independently associated with progression to rheumatoid arthritis.
Serum biomarkers can differentiate psoriatic arthritis, RA
Dec 21, 2021
A panel of serum protein biomarkers was identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis.
Subclinical synovitis may precede arthritis in anti-CCP2+ individuals
Dec 21, 2021
Anti-CCP3 antibodies were predictive for the development of ultrasound synovitis in anti-CCP2+ at-risk individuals
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Migraine linked to all-cause dementia, Alzheimer’s disease
Oct 07, 2021
No association was observed between migraine and a risk for vascular dementia in meta-analysis of five cohort studies.
Oral inosine does not slow progression of early Parkinson’s disease
Sep 16, 2021
No significant difference was seen in the rate of clinical disease progression or in secondary efficacy outcomes versus placebo.
